A partner and co-chair of the Litigation Department, Theodore V. Wells, Jr. has extensive litigation experience in white-collar criminal defense, complex civil and corporate litigation, SEC regulatory work, healthcare fraud, FCPA, AML and OFAC investigations, environmental matters and class action litigation.
In 2010 The National Law Journal named Ted one of “The Decade’s Most Influential Lawyers” and over the years has repeatedly selected him as one of the 100 most influential lawyers in America, including naming Ted as the Lawyer of the Year in 2006. Ted also has been recognized as one of the outstanding jury trial lawyers in the United States by numerous publications including Chambers USA, which in 2012 recognized him as “the best trial lawyer in the country.” Since 2013, Chambers USA has named Ted a Star Performer in three categories: nationwide trial litigation, New York general commercial litigation and New York white-collar crime and government investigations, and Benchmark Litigation named him in similar categories. The Legal 500 has recognized him as a Leading Lawyer in white-collar criminal defense and as a Leading Trial Lawyer.
In 2010, Ted successfully defended Citigroup in a three-week jury trial where the plaintiff, the London-based private equity firm Terra Firma, claimed it was defrauded in connection with its purchase of the music company EMI, and claimed over $8 billion in damages.
In 2008, Ted successfully defended Citigroup in a five-month jury trial where the plaintiff alleged that Citigroup aided and abetted in the massive fraud at Parmalat, the Italian dairy and food corporation. The jury totally rejected the $2 billion claim for damages against Citigroup and also awarded Citigroup $364 million on Citigroup's counterclaim.
In 2012, Ted served as lead trial counsel for Bank of America in the massive securities class action relating to Bank of America's acquisition of Merrill Lynch & Co. The case was settled on the eve of trial.
In 2013, Ted served as lead counsel for Merck in the massive securities fraud class action relating to the drug Vytorin. The case was settled on the eve of trial.
Ted was lead trial counsel for Merck in the federal regulatory investigations related to Vioxx and was lead counsel for Abbott Laboratories in the federal regulatory investigations relating to Depakote. Both the Vioxx and Depakote federal regulatory investigations were successfully settled in 2012.
Some of Ted's significant and publicly reported representations include:
In addition to defending a number of political figures, Ted has also represented numerous corporate executives and corporations in jury trials, grand jury investigations and before the SEC. Ted also has extensive experience in representing major pharmaceutical companies in criminal and civil matters involving off-label marketing issues.
More specifically, he has defended:
Ted also has extensive experience in representing major corporations in massive class action litigations, including Merck, Johnson & Johnson, Bank of America, Mitsubishi Corporation, Carnival Corporation and Philip Morris Corporation.
In addition, Ted has successfully defended major law firms in malpractice actions.
With extensive experience in corporate governance issues, Ted previously served on the Board of Directors of CIT Corporation, a New York Stock Exchange company, where he was a member of CIT's audit committee.
Ted is a fellow of the American College of Trial Lawyers. He has served as co-chair of the White-Collar Criminal Section of the National Association of Criminal Defense Lawyers. He has been a faculty member of the Practising Law Institute Trial Advocacy Program, a teaching team member of the Harvard Law School Trial Advocacy Workshop and a lecturer at the Securities Regulation Institute. He has lectured on the use and scope of the RICO statute, the defense of securities, healthcare and environmental criminal and civil matters, federal grand jury procedures and federal sentencing guidelines.
Active in social, political and community affairs, Ted served as national treasurer for Senator Bill Bradley's presidential campaign and is the chairman emeritus of the NAACP Legal Defense and Educational Fund Board of Directors. He previously served, on a pro bono basis, as general counsel to the New Jersey NAACP, New Jersey co-chairperson of the United Negro College Fund and general counsel to the New Jersey Democratic Party. Ted is a Fellow of the Harvard Corporation, the governing body of Harvard University.
Ted served as an editor of the Harvard Civil Rights-Civil Liberties Law Review.
See Library Tab for articles, publications and presentations by Theodore Wells
Jan 26, 2016 | Events
Nov 05, 2015 | Events
Sep 11, 2015 | Publications
Jul 17, 2015 | Publications
Apr 28, 2015 | News
Dec 15, 2015
Sep 14, 2015
Mar 18, 2015
Mar 04, 2015
Nov 19, 2014
Feb 20, 2014
Jun 07, 2013
Thank you for your interest in Lawdragon.